C4 Therapeutics, Inc. (CCCC) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading CCCC…

C4 Therapeutics, Inc. (CCCC) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

C4 Therapeutics, Inc.

CCCC · CIK 1662579

4 · Sep 21, 2026 · Chief Financial Officer Adams Kendra exercised options for 6,250 shares; reported 2,775 shares

4

Chief Financial Officer Adams Kendra exercised options for 6,250 shares; reported 2,775 shares

Filed: Sep 21, 2026
Period: Sep 18, 2026
Accession: 0001470831-26-000895
Filer: C4 Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/wk-form4_1790022287.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4wk-form4_1790022287.xml
Open SEC.gov